Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Liabilities and Shareholders Equity: 2014-2023

Historic Liabilities and Shareholders Equity for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to $209.7 million.

  • Cellectis' Liabilities and Shareholders Equity fell 24.99% to $209.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $950.0 million, marking a year-over-year decrease of 28.56%. This contributed to the annual value of $22.4 million for FY2022, which is 94.13% down from last year.
  • As of Q3 2023, Cellectis' Liabilities and Shareholders Equity stood at $209.7 million, which was down 7.89% from $227.7 million recorded in Q2 2023.
  • In the past 5 years, Cellectis' Liabilities and Shareholders Equity registered a high of $511.9 million during Q1 2019, and its lowest value of $209.7 million during Q3 2023.
  • Its 3-year average for Liabilities and Shareholders Equity is $326.6 million, with a median of $320.9 million in 2022.
  • In the last 5 years, Cellectis' Liabilities and Shareholders Equity skyrocketed by 57.98% in 2019 and then crashed by 32.29% in 2022.
  • Over the past 5 years, Cellectis' Liabilities and Shareholders Equity (Quarterly) stood at $467.5 million in 2019, then rose by 0.43% to $469.5 million in 2020, then decreased by 18.62% to $382.1 million in 2021, then slumped by 31.63% to $261.2 million in 2022, then fell by 24.99% to $209.7 million in 2023.
  • Its Liabilities and Shareholders Equity was $209.7 million in Q3 2023, compared to $227.7 million in Q2 2023 and $251.4 million in Q1 2023.